European Biosimilars Have ‘Room To Grow’ On Access And Understanding
Adrian Van Den Hoven, DG Of Medicines For Europe, Discusses Opportunities
• By David Wallace
Adrian van den Hoven shares his views on biosimilars in Europe • Source: Medicines for Europe 
